Expanded Access and Compassionate Use We will o
Post# of 72435
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
We will only consider Expanded Access/Compassionate Use if the following criteria are met:
1. A sufficient safety profile of an investigational drug has been determined;
2. if the Expanded Access / Compassionate Use will not interfere with or compromise clinical trials that could be used to support an FDA application for approval of the treatment;
3. and when there is an adequate supply of drug treatment for the necessary clinical trials before supplying drug treatment for Expanded Access / Compassionate Use patients.
http://www.ipharminc.com/expanded-access-and-...onate-use/
Is IPIX considering the program for B-OM and K?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)